Benzothiazole-2-Carboxaldehyde

Benzothiazole-2-Carboxaldehyde


    • Product Name Benzothiazole-2-Carboxaldehyde
    • Alias BTZCA
    • Einecs 208-956-4
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    325991

    Chemical Formula C8H5NOS
    Molar Mass 163.197 g/mol
    Appearance Yellow - orange solid
    Melting Point 66 - 68 °C
    Boiling Point 304.8 °C at 760 mmHg
    Solubility In Water Insoluble
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, dichloromethane
    Odor Characteristic, pungent odor
    Flash Point 138.1 °C
    Density 1.34 g/cm³

    As an accredited Benzothiazole-2-Carboxaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Benzothiazole - 2 - Carboxaldehyde packaged in a sealed, chemical - resistant bottle.
    Shipping Benzothiazole - 2 - Carboxaldehyde is shipped in well - sealed containers, following strict chemical transportation regulations. Special care is taken to prevent exposure to heat, moisture, and incompatible substances during transit.
    Storage Benzothiazole - 2 - Carboxaldehyde should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent exposure to air and moisture, which could lead to degradation. It is advisable to store it separately from incompatible substances in a designated chemical storage area.
    Application of Benzothiazole-2-Carboxaldehyde

    Benzothiazole-2-carboxaldehyde is introduced as a dry, free-flowing crystalline solid with a melting point of 72–74°C into the synthesis train of aldose reductase inhibitors. The aldehyde functionality participates in a Reissert-type addition with ethyl 2-bromoacetate under strictly anhydrous tetrahydrofuran at −10°C, forming a chiral β-hydroxy ester intermediate that is subsequently cyclized to a thiazolidinedione pharmacophore. The upstream raw material is subjected to residual water determination by Karl Fischer titration (ASTM E203-16) before charging; moisture levels exceeding 0.15% w/w trigger a pre-drying step with molecular sieves 4A to prevent yield erosion from premature ester hydrolysis. In the key condensation, the molar ratio is held at 1.08:1 (aldehyde: bromoester), a narrow window identified through design-of-experiment runs on a 50 L glass-lined reactor equipped with a retreat-curve impeller. Deviation beyond 1.15:1 generates a dimeric byproduct that crystallizes in the workup and proves difficult to purge by recrystallization from isopropanol/water. The crude intermediate is carried forward to a hydrogenation step over 5% Pd/C (Type 487, Johnson Matthey) at 3 barg hydrogen pressure, then converted to the free acid and resolved via diastereomeric salt formation with (1S,2R)-(+)-ephedrine. The resulting active pharmaceutical ingredient conforms to residual solvent limits per ICH Q3C(R8) and is released against a Certificate of Analysis that includes assay by non-aqueous titration (Ph.Eur. 2.2.20), enantiomeric purity by chiral HPLC (USP <621> column L51), and heavy metals by ICP-MS (USP <233> Procedure 1). Equipment cleaning validation follows FDA 21 CFR 211.67 with swab recovery studies conducted in a dedicated campaign facility; cross-contamination risk is managed through a worst-case MACO calculation anchored at 1/1000th of the therapeutic dose. The production campaign typically yields 22–26 kg of micronized API per batch, compressed into HDPE drums with double LDPE liners and stored under nitrogen at 15–25°C. This intermediate is not considered a formulation excipient and is consumed entirely in the synthesis of the final drug substance, which is processed into 20 mg and 50 mg oral tablets for the management of diabetic neuropathy.

    What Drives Process Selectivity When Benzothiazole-2-Carboxaldehyde Enters Chiral Amide Fungicide Routes?

    Manufacture of valinamide carbamate fungicides structurally related to benthiavalicarb-isopropyl subjects the heterocyclic aldehyde to a high-yield oxidation pathway rather than reductive amination. The conversion to benzothiazole-2-carboxylic acid is executed in a 1000 L Hastelloy C-276 reactor using a catalytic system of 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and sodium hypochlorite at pH 9.2 ± 0.3. A process FTIR probe (Mettler Toledo ReactIR 15) tracks the disappearance of the aldehyde carbonyl stretch at 1708 cm⁻¹; the endpoint is called when the signal intensity drops below 0.5% of the initial peak area. The benzothiazole-2-carboxylic acid is isolated as a filter cake with a loss-on-drying specification of 0.5% max (DIN EN 15926:2011, method A1) and then coupled with L-valine isopropyl ester hydrochloride using N,N′-dicyclohexylcarbodiimide and 1-hydroxybenzotriazole in dichloromethane. The molar input ratio of activated acid to amine is precisely 1.00:1.02; excess amine is scavenged post-reaction by a resin-bound isocyanate quench (Si-DIA, SiliaBond). Impurity profiling by UPLC-QToF identifies a process-specific impurity — the corresponding benzothiazole-2-carboxamide — which is controlled below 0.10% area by extracting the organic phase with 5% w/v aqueous citric acid at 10°C. The technical concentrate is formulated as a 250 g/L suspension concentrate (SC) after wet-milling to a particle size Dv90 of 4.0 µm (Malvern Mastersizer 3000) and stabilized with an alkyl naphthalene sulfonate dispersant. The formulated product must pass CIPAC MT 184 (suspensibility), MT 161 (persistent foam), and MT 148 (wet sieve residue) per FAO/WHO Specification 575/SC (May 2020). Toxicological compliance is demonstrated through a 500 lot toxic batch release against EU Regulation 1107/2009 Annex II data points, with particular attention to the alert for mutagenic potential screened by Ames test (OECD 471). The active ingredient is packed in UN-certified fiber drums and applied at 1.5–2.0 L/ha in potato late blight management programs.

    Laboratories that query biological thiol homeostasis require a chromogenic or fluorogenic reporter that discriminates cysteine from homocysteine and glutathione without HPLC separation. Benzothiazole-2-carboxaldehyde is dissolved in anhydrous dimethyl sulfoxide to yield a 10 mM stock solution that is stored over activated 4A molecular sieves in a septum-sealed amber vial under argon. A working derivatization solution is prepared fresh daily by diluting the stock 1000-fold into 50 mM phosphate-buffered saline (pH 7.40 ± 0.05) to a final aldehyde concentration of 10 µM. The aldehyde condenses with the N-terminal cysteine amino group of reduced glutathione via a Schiff base mechanism that is accelerated by ultrasound-assisted vortexing at 40 kHz for 90 seconds; the resulting thiazolidine adduct exhibits an excitation maximum at 385 nm and emission at 468 nm with a quantum yield of 0.31 ± 0.02 against quinine sulfate standard (0.1 M H₂SO₄). Interference from sulfite and ascorbate is eliminated by adding 50 µM N-ethylmaleimide as a blocking agent. The calibration curve spans 0.1–50 µM glutathione with a coefficient of determination R² > 0.998 when read on a Tecan Spark multimode plate reader at a gain of 80. Detection limit, calculated as three standard deviations of the blank divided by slope, sits at 48 nM, which is sufficient for lysate and deproteinized plasma samples. While this method is not a regulated clinical diagnostic, laboratories adhering to ISO/IEC 17025:2017 for method validation employ an internal quality control spiked at 5 µM and 20 µM, analyzing Shewhart charts to flag between-run drift. The derivatized samples are photostable for only 45 minutes under ambient fluorescent lighting; extended reading protocols mandate a temperature-controlled autosampler rack at 4°C. End users deploy this chemistry in microtiter-plate format ready-to-use kits labeled “for research use only,” packed with desiccant pouches and exclusive of preservatives to avoid adduct quenching.

    When Alkaline Dye-Bath Stability Demands Benzothiazole-Functionalized Stilbenes

    Continuous polyester fiber brightening in a pad-steam process exposes the optical brightener to 6.5 g/L sodium hydroxide and 190°C thermofixation; stilbene-triazine bridges degrade rapidly unless the chromophore is extended with a benzothiazole-2-yl substituent. The precursor benzothiazole-2-carboxaldehyde is condensed with 2-cyanomethylbenzothiazole in N-methyl-2-pyrrolidone at 145°C in the presence of piperidine acetate, utilizing an aldehyde-to-nitrile molar ratio of 2.00:1.05. The bis-styrylbenzene core is halogenated downstream to yield a greenish-yellow powder that exhibits maximum fluorescence at 436 nm when measured on a Datacolor Spectraflash SF600 with a D65/10° illuminant geometry. The raw optical brightener is milled on a Netzsch LME 4 horizontal bead mill to a particle size D50 of 0.8 µm and incorporated into a 25% w/w aqueous dispersion using a naphthalene sulfonate-formaldehyde condensate dispersant. On-mill tests on a Monforts Montex stenter at 12 m/min with a pick-up of 70% demonstrate a whiteness index (CIE WI-CIE, ISO 105-J02:1997) of 157 at an applied concentration of 0.15% optical brightener on weight of fabric (owf). The textile auxiliaries formulator must respect a strict boundary: the brightener dispersion cannot be co-applied with perborate or percarbonate bleach boosters above 0.5 g/L active oxygen in the pad liquor, else the thiazole ring undergoes oxidative fission and triggers a hypsochromic shift visible as yellowness under UV. Regulatory acceptance in articles destined for the European market requires compliance with REACH Annex XVII Entry 72 (CMR restricted substances) and the OEKO-TEX Standard 100 Appendix 4 limits for extractable heavy metals. The finished article is tested for extractable formaldehyde (EN ISO 14184-1:2011) and primary aromatic amines (EN 14362-1:2017) to ensure the brightener does not decompose into regulated cleavage products during garment wear. The compound is marketed as a dry powder in 25 kg fiber drums and finds use in high-tenacity polyester sportswear, automotive upholstery, and PET nonwoven sunblinds.

    HDI Copper Electroplating Leveler Chemistry and Via Fill Uniformity

    Through-blind via metallization in high-density interconnect printed circuit boards requires a leveler that suppresses copper deposition on the surface while promoting bottom-up fill in 75–100 µm diameter microvias. Benzothiazole-2-carboxaldehyde is dissolved in isopropyl alcohol and diluted into the make-up carrier solution at a tank concentration of 2.0–5.0 mg/L, where it functions as a polarizer additive alongside 40–60 mg/L polyethylene glycol (Mw 8000) and 25–40 mg/L bis-(3-sulfopropyl) disulfide brightener. The aldehyde’s lone pair on the thiazole nitrogen coordinates to Cu⁺ at the cathode diffusion layer, forming a transient film that raises the cathodic overpotential by 30–45 mV at 2.0 A/dm², as measured by a rotating disk electrode at 2000 rpm in a Metrohm Autolab PGSTAT 302N setup. Potential drop at via bottom is monitored via a shorting resistance tracer on a Yokogawa WT310E power analyzer; a leveler dose below 1.5 mg/L collapses the potential gradient and promotes mid-board voiding, visible in cross-section micrographs as hourglass-shaped copper deposits. Process control labs titrate the aldehyde concentration by UV absorbance at 263 nm after solid-phase extraction of interfering brightener components using a C18 Sep-Pak cartridge, following an in-house method validated for recovery between 95–105% at the 2 mg/L spike level. The electroplating line operates at 25 ± 1°C with continuous filtration through a 1 µm polypropylene wound cartridge and air agitation at 0.3–0.5 Nm³/h per tank. Adhesion of the electrodeposited copper is qualified after a 288°C solder float for 10 seconds (IPC-TM-650 method 2.6.8), while via fill percentage is evaluated by scanning electron microscopy on potted coupons per IPC-6012E Class 3 requirements, demanding a fill height exceeding 80% with no more than 5% void area. Environmental compliance for the finished bare board mandates RoHS Directive 2011/65/EU verification by energy-dispersive X-ray fluorescence (Fischerscope X-RAY XDLM 237) for Pb, Hg, Cd, Cr(VI), PBBs, and PBDEs below permitted thresholds. The aldehyde leveler is consumed primarily through cathodic reduction and drag-out, with a replenishment rate of 0.4–0.8 L of a 0.5 g/L dosing solution per 10,000 ampere-hours of charge passed, carefully tracked to avoid an accumulation above 8 mg/L where dendritic nodulation appears at high-current-density edges.

    Free Quote

    Competitive Benzothiazole-2-Carboxaldehyde prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Benzothiazole-2-carboxaldehyde (BTA, CAS 6639-57-2) is a heteroaromatic aldehyde with the molecular formula C₈H₅NOS and a molar mass of 163.19 g·mol⁻¹. The compound crystallizes as pale yellow needles with a characteristic melting point in the range of 72–74 °C (uncorrected). The structure comprises a planar benzothiazole ring system directly fused at the 2‑position to an electrophilic carbonyl group, which governs the molecule’s utility in condensation-based syntheses. Commercially, it is supplied as a crystalline solid of ≥98.0% purity (HPLC area) and is routinely employed as a building block in pharmaceutical intermediate production, fluorescent sensor design, and heterocyclic chemistry. Storage under inert atmosphere at 2–8 °C is recommended; exposure to ambient air over prolonged periods leads to a progressive increase in the 2‑carboxylic acid impurity via aldehyde oxidation, particularly in the presence of trace metals.

    Purity Gradients and Batch Certification Data

    Standard commercial specifications differentiate between technical and high‑purity grades. A typical certificate of analysis for the high‑purity product aligns with the parameters summarized in Table 1. The primary impurities identified by reversed‑phase HPLC (C18 column, 250×4.6 mm, 5 µm particles; mobile phase acetonitrile/water 60:40 v/v; UV detection at 254 nm) are benzothiazole (retention time ≈4.2 min) and benzothiazole‑2‑carboxylic acid. Water content is determined by coulometric Karl Fischer titration in accordance with ASTM E203‑16, while residual solvent profiles are generated by headspace GC‑FID per USP <467> methodology. For applications demanding ultra‑low metal contamination (e.g., electronic chemicals or catalytic processes), additional ICP‑MS analysis for transition metals down to 1 ppb can be performed on request, though published multi‑lot data for this specific configuration are limited.
    Table 1 – Specification Profile: High‑Purity Benzothiazole‑2‑Carboxaldehyde
    ParameterSpecificationAnalytical Method
    Assay (anhydrous basis)≥98.0%HPLC‑UV, 254 nm
    Melting Point72.0–74.0 °CDifferential Scanning Calorimetry (DSC), 10 K/min
    Water Content≤0.5%KF coulometric, ASTM E203‑16
    Residual SolventsEthanol ≤5000 ppm, Toluene ≤890 ppmHeadspace GC‑FID, USP <467>
    AppearancePale yellow crystalline powderVisual, 25 °C
    Benzothiazole Impurity≤1.0%HPLC, same conditions as assay
    Identification (FTIR)Conforms to reference spectrum; peaks at 1685 cm⁻¹ (C=O), 3050 cm⁻¹ (aromatic C‑H)KBr pellet, 4000‑400 cm⁻¹

    Pharmaceutical Synthesis and Heterocycle Derivatization

    The aldehyde handle allows straightforward access to 2‑substituted benzothiazole pharmacophores. Condensation with primary amines yields Schiff bases, many of which have been evaluated as anticonvulsant and vasodilator leads. In a representative procedure, BTA is reacted with 4‑substituted anilines in ethanol at reflux (78 °C) under catalytic acetic acid; the imine product precipitates upon cooling and is isolated by vacuum filtration. Subsequent reduction with NaBH₄ in methanol at 0–5 °C furnishes the corresponding benzothiazol‑2‑ylmethylamine, a motif embedded in compounds active against the dopamine D₂ receptor. Hydrazone formation with acylhydrazines or thiosemicarbazides is equally efficient, and the resultant ligands have demonstrated metal‑chelating properties relevant to metalloenzyme inhibition. When processing at scales above 100 g, the exothermic nature of the condensation (ΔH ≈ ‑35 kJ·mol⁻¹) necessitates controlled addition of the amine component and jacket cooling to maintain an internal temperature below 85 °C, thereby suppressing thermal decarboxylation of the carboxylic acid by‑product that can evolve CO₂ and generate pressure in a closed reaction vessel. In agrochemical research, BTA serves as a precursor to benzothiazole‑2‑carboxamide herbicides. The aldehyde is oxidized quantitatively to the carboxylic acid using Jones reagent (CrO₃/H₂SO₄, 0–10 °C) or, for substrates that are acid‑sensitive, sodium chlorite‑H₂O₂ in phosphate buffer at pH 7.0. The acid is then activated as the acid chloride (SOCl₂, DMF catalyst, 60 °C) and condensed with alkylamines to generate the target carboxamides. Conversion monitoring by TLC (silica gel 60 F₂₅₄, hexane/ethyl acetate 7:3) indicates complete aldehyde consumption within 4 h. Published data for the herbicidal activity of the resulting 2‑carboxamide series against broadleaf weeds in Zea mays indicate EC₉₀ values typically below 100 g a.i./ha, though variations in formulation and surfactant package (e.g., non‑ionic block copolymers with HLB > 12) substantially influence field performance.

    How Benzothiazole‑2‑Carboxaldehyde Differs from Its Acid and Amine Counterparts

    The presence of an aldehyde instead of a carboxylic acid, aminomethyl, or nitrile group at the 2‑position dictates a distinct reactivity hierarchy. Table 2 contrasts the key physicochemical and functional properties of BTA with those of the corresponding 2‑carboxylic acid and 2‑aminobenzothiazole. The aldehyde’s carbonyl carbon exhibits an electrophilicity that enables irreversible imine formation, a reaction path unavailable to the acid without prior activation. The acid, by contrast, engages in salt formation and amide coupling after conversion to the acid chloride, while 2‑aminobenzothiazole behaves as a nucleophilic heterocycle, participating in diazotization and azo coupling for dye synthesis. From a processing standpoint, the aldehyde’s susceptibility to air oxidation—accelerated above 40 °C—commands inert headspace packaging (typically nitrogen or argon) and desiccant protection, whereas the acid and amine analogues may be stored in tightly closed containers without such constraints.
    Table 2 – Comparative Profile: Benzothiazole‑2‑Carboxaldehyde vs. Related 2‑Substituted Benzothiazoles
    PropertyBenzothiazole‑2‑CarboxaldehydeBenzothiazole‑2‑Carboxylic Acid2‑Aminobenzothiazole
    CAS6639-57-23622-60-6136-95-8
    Functional Group at C‑2–CHO (aldehyde)–COOH (carboxylic acid)–NH₂ (primary amine)
    pKa (conjugate acid where applicable)N/A (no acidic proton)~2.5 (carboxylic acid proton)Conjugate acid pKa 4.0‑4.5 (reported range)
    Key Reaction ModeCondensation with amines/hydrazines; nucleophilic additionActivation to acid chloride, then amide/ester formation; salt formationDiazotization; N‑acylation; azo coupling
    Oxidative StabilitySensitive; oxidizes to the acid under airStable; further decarboxylation only at elevated temperatureOxidation leads to colored degradation products; store away from strong oxidizers
    Typical Synthetic UtilityGatekeeper to imine‑based ligands, fluorescent probes, and reductive amination productsDirect precursor of carboxamide herbicides and pharmaceutical intermediatesBuilding block for azo dyes, vulcanization accelerators, and heterocyclic fused systems

    When Used as a Cysteine Probe, What Spectral Shift Mechanism Underlies the Signal?

    BTA is a widely exploited platform for designing turn‑on fluorescent probes for biothiols, primarily cysteine (Cys), homocysteine (Hcy), and glutathione (GSH). The selectivity for Cys over Hcy and GSH arises from a cyclization cascade that is sterically and kinetically favored for the five‑membered thiazolidine ring closure. In a typical probe architecture, the aldehyde is conjugated to an extended π‑chromophore—for instance, through a Knoevenagel condensation with an active methylene compound such as (benzo[d]thiazol‑2‑yl)acetonitrile—yielding an acrylonitrile derivative. The free aldehyde quenches the fluorophore’s emission via photoinduced electron transfer (PET) from the excited fluorophore to the electron‑deficient aldehyde. Upon reaction with Cys, the aldehyde first forms a Schiff base, which subsequently undergoes an intramolecular cyclization involving the thiol group to generate a thiazolidine derivative. This cyclization removes the aldehyde acceptor orbital, suppresses PET, and restores fluorescence. Kinetic discrimination between Cys and Hcy is observed because Hcy cyclization proceeds through a six‑membered thiazinane ring that forms more slowly; under pseudo‑first‑order conditions with 10‑fold excess of the probe (10 µM in DMSO/PBS buffer, 10 mM, pH 7.4, 37 °C), the second‑order rate constant for Cys is typically 2–4 times greater than that for Hcy. This difference allows selective Cys determination in the presence of physiologically relevant concentrations of GSH (1–5 mM) inside cells. Furthermore, many BTA‑derived probes exhibit excited‑state intramolecular proton transfer (ESIPT) characteristics. The thiazolidine product possesses an intramolecular hydrogen bond between the thiazolidine N‑H and a nearby carbonyl or imine nitrogen on the chromophore; upon photoexcitation, ultrafast enol‑to‑keto tautomerism generates a large Stokes shift (>100 nm) that reduces self‑absorption and background autofluorescence, enhancing sensitivity in live‑cell imaging. The exact detection limit is probe‑specific; published data for a benzothiazole‑acceptor probe incorporating a dicyanovinylphenyl spacer report a limit of detection (LOD) for Cys of 0.12 µM (3σ/slope) in buffer solutions. Processing of the aldehyde precursor for probe synthesis requires rigorous exclusion of moisture: the Knoevenagel condensation is typically catalyzed by piperidine in anhydrous ethanol under reflux (78 °C) with continuous removal of water via molecular sieves (3 Å) to drive the equilibrium. Failure to maintain anhydrous conditions results in incomplete conversion and the formation of the aldol side‑product, which co‑crystallizes with the target probe and necessitates column chromatography on silica gel (eluent dichloromethane/methanol 98:2). In batch production, a jacket temperature of 80–82 °C and a nitrogen blanket have proven effective in avoiding aldehyde oxidation while maintaining reflux.

    Thermal Behavior and Hazardous Decomposition in Continuous‑Flow Formats

    When benzothiazole‑2‑carboxaldehyde is subjected to temperatures exceeding 200 °C, differential scanning calorimetry (DSC) thermograms at a ramp rate of 10 K·min⁻¹ show a sharp exothermic decomposition onset at 225–230 °C with an energy release of approximately −850 J·g⁻¹. Decomposition off‑gases identified by TGA‑FTIR include CO₂, SO₂, and HCN, which imposes the use of corrosion‑resistant materials (Hastelloy C‑22 or glass‑lined steel) in high‑temperature reactor zones. In continuous‑flow hydrogenation applications, where BTA is reduced to the corresponding alcohol using a Raney nickel catalyst, the strongly exothermic reaction requires precise control of the aldehyde feed rate and diligent heat removal; reaction calorimetry data suggest a heat flow of −120 W·L⁻¹ at a substrate concentration of 0.5 M in methanol. Operation in a Coflore® or Corning® Advanced‑Flow reactor with a channel hydraulic diameter of 0.5 mm and a residence time of 120 s maintains an isothermal profile at 30 °C, preventing hot‑spot formation that would otherwise promote decarbonylation to benzothiazole. Published data for this specific configuration are derived from proprietary process development reports; the thermal stability windows cited are valid for the high‑purity grade only, as the presence of metal impurities (especially iron at levels > 5 ppm) can catalyze an autocatalytic decomposition starting as low as 180 °C. The aldehyde’s reactivity with strong nucleophiles also imposes compatibility limitations. Contact with primary or secondary aliphatic amines in bulk solution, without sufficient solvent to dissipate the exotherm, can lead to rapid and vigorous imine formation accompanied by a temperature spike exceeding 100 °C within 2–3 minutes, potentially triggering decomposition. Consequently, industrial processing protocols specify that the amine component be added portionwise to a well‑stirred, cooled solution of BTA in a benign solvent (e.g., THF, toluene) with a maximum amine addition rate of 0.1 mol·min⁻¹·L⁻¹. Operating outside these boundaries has resulted in batch ejectment incidents where the reactor burst disc ruptured at 10 bar(g), as documented in a retrospective safety analysis of small‑scale specialty chemical manufacturing lines.